To view this information click here practitioners , clinical nurse specialists , certified registered nurse anesthetists and anesthesiologist assistants , and certified nurse-midwives . This information is available on the CMS website . Review all randomized , controlled , peer-reviewed studies for COI disclosure ( s ) by the author ( s ). Know your organization ’ s policies to insure you adhere to organizational compliance guidelines , comply with disclosure and confidentiality policies , and can serve as a resource for internal and external customers .
Pitfall
5
When is a trial necessary ?
Trusting you have established the need for the proposed products and the product requirements , if there is no randomized controlled , peer-reviewed studies to support the efficacy of the product , you may need to conduct a trial to verify efficacy . A trial is most often requested for a new product / device / pharmaceutical for which there is little or no published information .
The identified need and the product requirements and anticipated measurable value will provide the criteria on which you will evaluate the efficacy . Before proceeding with a trial , meet with SMEs to determine either the length of the trial or the number of uses necessary for an adequate determination of efficacy .
Information about existing products currently in use at organizations within your GPO , health system or at regional organizations may provide sufficient evidence of targeted efficacy , safety and patient outcomes in lieu of a trial .
Pitfall
6
What if we are not achieving the measureable value we projected for the approved product / device / pharmaceutical ?
Following implementation , it is critically important to ensure you are achieving the measureable value identified . Follow up at three months , six months , one year and annually thereafter to verify you are achieving the projected outcomes . If not , why not ? Has old product been removed from inventory ? Is additional education required ? Determine the root cause and work with SMEs to remedy the situation .
Taking time to apply the discipline of healthcare value analysis can help you and your team avoid these pitfalls . Once you realize the identified value , recognize the contributions made by team members and communicate and celebrate your success .
Mary E . Potter , RN , BS , CVAHP , is an independent value analysis consultant .
HEALTHCARE FACILITIES • AMBULATORY SURGERY CENTERS • ENDOSCOPY CENTERS • DIAGNOSTIC RADIOLOGY
Is flexible endoscope reprocessing keeping you awake at night ? Is your current process adhering to regulatory standards ?
Are your endoscopy technicians trained to perform a safe and effective process without omitting critical steps ?
Let OSPECS Consulting help you remove the issues impacting successful flexible endoscope reprocessing
What we offer
• Comprehensive Assessment of the High-Level Disinfection ( HLD ) process
• Workflow Analysis and Opportunity Identification
• Accreditation Readiness and Rapid Corrective Action Programs
• Customized On-Site Hands-On Flexible Endoscope and Classroom Training
• Expert assistance in New Construction Design and Renovation Strategic Planning